Showing 1 - 8 results of 8 for search 'Shixue Liu', query time: 0.03s
Refine Results
-
1
The molecular pathogenesis of SOX2 in prostate cancer by Shixue Liu, Honglian Yu, Zhankui Zhao
Published 2025-02-01
Article -
2
A Microscale Modeling Tool for the Design and Optimization of Solid Oxide Fuel Cells by Shixue Liu, Zijing Lin, Wei Kong
Published 2009-06-01
Article -
3
Personalised treatment assignment maximising expected benefit with smooth hinge loss by Shixue Liu, Jun Shao, Menggang Yu
Published 2017-01-01
Article -
4
Retinal changes of primary vitreoretinal lymphoma after intravitreal methotrexate by Tingting Jiang, Junxiang Gu, Shixue Liu, Qing Chang
Published 2022-09-01
Article -
5
Optimization of the Interconnect Ribs for a Cathode-Supported Solid Oxide Fuel Cell by Wei Kong, Xiang Gao, Shixue Liu, Shichuan Su, Daifen Chen
Published 2014-01-01
Article -
6
Cell-Free DNA Sequencing of Intraocular Fluid as Liquid Biopsy in the Diagnosis of Vitreoretinal Lymphoma by Junxiang Gu, Junxiang Gu, Junxiang Gu, Tingting Jiang, Tingting Jiang, Tingting Jiang, Shixue Liu, Shixue Liu, Shixue Liu, Bo Ping, Ruiwen Li, Wenwen Chen, Wenwen Chen, Wenwen Chen, Ling Wang, Ling Wang, Ling Wang, Xin Huang, Xin Huang, Xin Huang, Gezhi Xu, Gezhi Xu, Gezhi Xu, Qing Chang, Qing Chang, Qing Chang
Published 2022-07-01
Article -
7
Efficacy and safety of tofacitinib modified-release 11 mg once daily plus methotrexate in adult patients with rheumatoid arthritis: 24-week open-label phase results from a phase 3b... by Boulos Haraoui, Janet Pope, Edward C Keystone, Eduardo Mysler, Tatjana Lukic, Harry Shi, Stanley B Cohen, Rebecca Germino, Lori Stockert, Annette Diehl, Sujatha Menon, Shixue Liu
Published 2021-08-01
Article -
8
Efficacy and safety of tofacitinib in Chinese patients with active psoriatic arthritis: a phase 3, randomised, double-blind, placebo-controlled study by Xiaofeng Zeng, Cunshan Wang, Yi Liu, Jian Xu, Ju Liu, Zhuoli Zhang, Wenfeng Tan, Shengyun Liu, Wei Lin, Weiguo Wan, Zhenyu Jiang, Zhiyi Zhang, Oluwaseyi Dina, Shixue Liu, XiaoMei Leng, Keith Kanik, Jiankang Hu, Jingyang Li, Levent M. Gunay, Cassandra Kinch
Published 2023-01-01
Article